Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Neuroendocrinology in 2011].
Puig Domingo M, Castaño J, Alvarez-Escolá C, Resmini E, Venegas E, García Arnés J, Torres E, Lecumberri B, Barahona MJ, Lamas C, Fajardo C, Cámara R, Vicente A, Blanco C, Villabona C, Del Pozo C, Halperin I, Salinas I, Sesmilo G, Aller J, Marazuela M, Webb SM, Bernabeu I. Puig Domingo M, et al. Among authors: aller j. Endocrinol Nutr. 2012 May;59(5):311-25. doi: 10.1016/j.endonu.2012.01.009. Epub 2012 Mar 16. Endocrinol Nutr. 2012. PMID: 22425316 Spanish. No abstract available.
Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus.
Bernabeu I, Aller J, Álvarez-Escolá C, Fajardo-Montañana C, Gálvez-Moreno Á, Guillín-Amarelle C, Sesmilo G. Bernabeu I, et al. Among authors: aller j. Endocrinol Diabetes Nutr (Engl Ed). 2018 May;65(5):297-305. doi: 10.1016/j.endinu.2018.01.008. Epub 2018 Apr 10. Endocrinol Diabetes Nutr (Engl Ed). 2018. PMID: 29653911 English, Spanish.
Pasireotide in the Personalized Treatment of Acromegaly.
Puig-Domingo M, Bernabéu I, Picó A, Biagetti B, Gil J, Alvarez-Escolá C, Jordà M, Marques-Pamies M, Soldevila B, Gálvez MA, Cámara R, Aller J, Lamas C, Marazuela M. Puig-Domingo M, et al. Among authors: aller j. Front Endocrinol (Lausanne). 2021 Mar 16;12:648411. doi: 10.3389/fendo.2021.648411. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33796079 Free PMC article. Review.
Long-term treatment with pegvisomant for acromegaly: a 10-year experience.
Ramos-Leví AM, Bernabeu I, Álvarez-Escolá C, Aller J, Lucas T, de Miguel P, Rodríguez-Cañete L, Sampedro-Núñez MA, Halperin I, Puig-Domingo M, Marazuela M. Ramos-Leví AM, et al. Among authors: aller j. Clin Endocrinol (Oxf). 2016 Apr;84(4):540-50. doi: 10.1111/cen.12993. Epub 2016 Jan 26. Clin Endocrinol (Oxf). 2016. PMID: 26662620
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study.
Sesmilo G, Resmini E, Bernabeu I, Aller J, Soto A, Mora M, Picó A, Fajardo C, Torres E, Alvarez-Escolá C, García R, Blanco C, Cámara R, Gaztambide S, Salinas I, Pozo CD, Castells I, Villabona C, Biagetti B, Webb SM. Sesmilo G, et al. Among authors: aller j. Clin Endocrinol (Oxf). 2014 Dec;81(6):883-90. doi: 10.1111/cen.12440. Epub 2014 Mar 19. Clin Endocrinol (Oxf). 2014. PMID: 24612232
Translational research in neuroendocrine tumors: pitfalls and opportunities.
Capdevila J, Casanovas O, Salazar R, Castellano D, Segura A, Fuster P, Aller J, García-Carbonero R, Jimenez-Fonseca P, Grande E, Castaño JP. Capdevila J, et al. Among authors: aller j. Oncogene. 2017 Apr 6;36(14):1899-1907. doi: 10.1038/onc.2016.316. Epub 2016 Sep 19. Oncogene. 2017. PMID: 27641330 Review.
92 results